Search

Nu Skin Enterprises Inc

Ouvert

10.25 2.09

Résumé

Variation du prix de l'action

24h

Actuel

Min

9.89

Max

10.32

Chiffres clés

By Trading Economics

Revenu

-4M

17M

Ventes

-22M

364M

P/E

Moyenne du Secteur

4.466

15.467

BPA

0.34

Rendement du dividende

2.5

Marge bénéficiaire

4.689

Employés

3,100

EBITDA

-11M

32M

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

2.50%

7.13%

Prochains Résultats

12 févr. 2026

Date du Prochain Dividende

4 mars 2026

Date du Prochain Détachement de Dividende

23 févr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-53M

477M

Ouverture précédente

8.16

Clôture précédente

10.25

Score Technique

By Trading Central

Confiance

Bearish Evidence

Nu Skin Enterprises Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

7 janv. 2026, 23:11 UTC

Résultats

Samsung Electronics Expects Record Fourth-Quarter Profit Beat

7 janv. 2026, 22:55 UTC

Principaux Mouvements du Marché

Defense Stocks Rebound After Trump Says He Wants $1.5 Trillion Military Budget in 2027

7 janv. 2026, 21:39 UTC

Principaux Mouvements du Marché

Raytheon Down Following Trump Post Criticizing Company

7 janv. 2026, 20:13 UTC

Principaux Mouvements du Marché

AbbVie, Revolution Medicines Stocks Gain on Report of Possible Acquisition

7 janv. 2026, 20:03 UTC

Principaux Mouvements du Marché

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Executive Pay

7 janv. 2026, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

7 janv. 2026, 23:46 UTC

Market Talk

Nikkei May Decline as China-Japan Tensions Linger -- Market Talk

7 janv. 2026, 23:42 UTC

Acquisitions, Fusions, Rachats

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 5th Update

7 janv. 2026, 23:34 UTC

Market Talk

Gold Edges Higher Amid Lingering Geopolitical Risks -- Market Talk

7 janv. 2026, 23:29 UTC

Acquisitions, Fusions, Rachats

Constellation Closes Deal for Calpine, Creating Biggest Electricity Generator -- Barrons.com

7 janv. 2026, 22:48 UTC

Market Talk

Infratil's Discount to Net Asset Value Too Good to Ignore -- Market Talk

7 janv. 2026, 22:46 UTC

Résultats

Samsung Electronics Estimates 2025 Rev KRW332.770T Vs KRW300.870T >005930.SE

7 janv. 2026, 22:45 UTC

Résultats

Samsung Electronics Estimates 2025 Oper Pft KRW43.530T Vs KRW32.730T >005930.SE

7 janv. 2026, 22:43 UTC

Acquisitions, Fusions, Rachats

Revolution Medicines Draws Takeover Interest -- 2nd Update

7 janv. 2026, 22:42 UTC

Résultats

Samsung Electronics 4Q Oper Pft Estimate Beat FactSet-Compiled Consensus Forecast

7 janv. 2026, 22:41 UTC

Résultats

Samsung Electronics Sees 4Q Oper Pft KRW20.000T Vs KRW6.490T >005930.SE

7 janv. 2026, 22:41 UTC

Résultats

Samsung Electronics Sees 4Q Rev KRW93.000T Vs KRW75.790T >005930.SE

7 janv. 2026, 22:40 UTC

Principaux Mouvements du Marché

Defense Stocks Rebound After Trump Says He Wants $1.5T Military Budget in 2027

7 janv. 2026, 22:31 UTC

Market Talk

Macro Tailwinds Strengthen for Chalice Mining -- Market Talk

7 janv. 2026, 22:22 UTC

Market Talk

Northern Star's Run of Disruptions Increasingly a Concern -- Market Talk

7 janv. 2026, 22:01 UTC

Market Talk

Valuations of New Zealand Property Stocks Supportive -- Market Talk

7 janv. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

7 janv. 2026, 21:46 UTC

Market Talk

Northern Star's Revised Guidance Looks Achievable -- Market Talk

7 janv. 2026, 21:22 UTC

Acquisitions, Fusions, Rachats

Eli Lilly to Buy Ventyx Biosciences for $14 a Share >LLY VTYX

7 janv. 2026, 21:18 UTC

Acquisitions, Fusions, Rachats

Lilly To Acquire Ventyx Biosciences To Advance Oral Therapies Targeting Inflammatory-mediated Diseases >LLY VTYX

7 janv. 2026, 21:05 UTC

Acquisitions, Fusions, Rachats

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 4th Update

7 janv. 2026, 20:29 UTC

Acquisitions, Fusions, Rachats

AbbVie Near Deal for Revolution Medicines -- Update

7 janv. 2026, 20:27 UTC

Market Talk

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

7 janv. 2026, 19:58 UTC

Market Talk

Oil Falls As U.S. to Receive Sanctioned Venezuelan Crude -- Market Talk

7 janv. 2026, 19:48 UTC

Principaux Mouvements du Marché

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Exec Pay

Nu Skin Enterprises Inc prévision

Note du Consensus

By TipRanks

0 ratings

0

Achat

0

Maintien

0

Vente

Score Technique

By Trading Central

5.78 / 6.16Support & Résistance

Court Terme

Bearish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Neutral Evidence

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Nu Skin Enterprises Inc

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
help-icon Live chat